ArticleMolecular cancer2021
Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models.
Abstract readLetter
In one paragraph
Article in Molecular cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- A chemo-free thermo-sensitive necroptosis-inducing perfusate to enable potent hyperthermic intraperitoneal immunotherapy.National science review · 2026Article
- Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?Annals of surgical oncology · 2026Article
- Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025.Molecular cancer · 2025Review
- Single-cell landscape of malignant ascites from patients with metastatic colorectal cancer.Cancer communications (London, England) · 2024Article
- CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer.Scientific reports · 2024Article
- Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment.International journal of molecular sciences · 2023Review
- Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer.Genes & genomics · 2023Article
- Patient-derived xenograft models in cancer therapy: technologies and applications.Signal transduction and targeted therapy · 2023Review
- Pan-cancer molecular subtypes of metastasis reveal distinct and evolving transcriptional programs.Cell reports. Medicine · 2023Article
- Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data.Cancers · 2021Article
- New advances in the use of patient-derived organoids and mouse models for assessing heterogeneity among metastatic colorectal cancers.Cell transplantationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Mathias Dahlmann *Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany.ORCID 0000-0002-0036-5283
Guido Gambara *German Cancer Consortium (DKTK), Heidelberg, im Neuenheimer Feld 280, 69120, Heidelberg, Germany.ORCID 0000-0001-8921-2568
Bernadette Brzezicha *EPO GmbH Berlin-Buch, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Oliver PoppProteomics Platform, Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Robert-Rössle-Str. 10, 13125, Berlin, Germany.ORCID 0000-0001-6240-4666
Eva PachmayrDepartment of Surgery, Charité - University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Lena WedekenCELLphenomics GmbH, Robert-Rössle-Str. 10, 13125, Berlin, Germany.ORCID 0000-0003-1061-9459
Alina PflaumeCELLphenomics GmbH, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Margarita MokritzkijTranslational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Safak Gül-KleinDepartment of Surgery, Charité - University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.ORCID 0000-0003-1013-7126
Andreas BrandlDepartment of Surgery, Charité - University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.ORCID 0000-0003-1990-2584
Caroline Schweiger-EisbacherGerman Cancer Consortium (DKTK), Heidelberg, im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Philipp MertinsProteomics Platform, Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health, Robert-Rössle-Str. 10, 13125, Berlin, Germany.ORCID 0000-0002-2245-528X
Jens HoffmannEPO GmbH Berlin-Buch, Robert-Rössle-Str. 10, 13125, Berlin, Germany.ORCID 0000-0003-3880-1658
Ulrich Keilholz *German Cancer Consortium (DKTK), Heidelberg, im Neuenheimer Feld 280, 69120, Heidelberg, Germany.ORCID 0000-0001-6773-9406
Wolfgang Walther *Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany.ORCID 0000-0003-2360-1370
Christian Regenbrecht *CELLphenomics GmbH, Robert-Rössle-Str. 10, 13125, Berlin, Germany.ORCID 0000-0001-9494-5977
Beate Rau *Department of Surgery, Charité - University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.ORCID 0000-0001-5820-6907
Ulrike Stein *Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Str. 10, 13125, Berlin, Germany. ustein@mdc-berlin.de.ORCID 0000-0001-7006-282X
Funding
Euopean Fund for Regional Development EFRE 1.8/09
Abstract
PubMed holds no abstract for this paper.
Indexed as
Biomarkers, TumorAnimalsColorectal NeoplasmsDisease Models, AnimalGenomicsHumansIn Vitro TechniquesPeritoneal NeoplasmsPrecision MedicinePrognosisTranslational Research, BiomedicalBiomarkers, Tumor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.